Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegaly-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegaly

Published:2009-08 Issue:2 Volume:71 Page:237-245
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Colao Annamaria,Auriemma Renata S.,Rebora Alberto,Galdiero Mariano,Resmini Eugenia,Minuto Francesco,Lombardi Gaetano,Pivonello Rosario,Ferone Diego

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2008.03503.x/fullpdf

Reference31 articles.

1. Lanreotide Autogel in the management of acromegaly;Molitch;Drugs,2008

2. Lanreotide Autogel: a review of its use in the management of acromegaly;Croxtall;Drugs,2008

3. Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers;Antonijoan;Journal of Pharmacy and Pharmacology,2004

4. Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly;Caron;Journal of Clinical Endocrinology and Metabolism,2002

5. Efficacy of lanreotide Autogel administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial;Lucas;Clinical Endocrinology,2006

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Medical treatment of functional pituitary adenomas, trials and tribulations;Journal of Neuro-Oncology;2024-05-18

3. Investigation of the Relationship between Adenoma Volume and Perioperative Hormone Levels in Patients with Acromegaly;European Journal of Therapeutics;2023-09-17

4. Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience;Journal of Endocrinological Investigation;2023-03-09

5. A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly;Pituitary;2022-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3